Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caffeic Acid Tablets for ITP
NCT02351622Phase 3Completed
- Sponsor
- Shandong University
- Start
- Sep 2012
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in immune thrombocytopenia (ITP) comparing Caffeic acid + Dexamethasone with Placebo + Dexamethasone (2 arms). Primary endpoint: Response to ITP treatments at 3 months. Started Sep 2012; status: completed.
02
Drugs
caffeic acid
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT02351622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02351622.